245 related articles for article (PubMed ID: 33794275)
21. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
22. Patient-derived organoids for therapy personalization in inflammatory bowel diseases.
Lucafò M; Muzzo A; Marcuzzi M; Giorio L; Decorti G; Stocco G
World J Gastroenterol; 2022 Jun; 28(24):2636-2653. PubMed ID: 35979165
[TBL] [Abstract][Full Text] [Related]
23. Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens.
Lees EA; Forbester JL; Forrest S; Kane L; Goulding D; Dougan G
J Vis Exp; 2019 May; (147):. PubMed ID: 31132035
[TBL] [Abstract][Full Text] [Related]
24. Retinoic Acid Promotes the In Vitro Growth, Patterning and Improves the Cellular Composition of Human Pluripotent Stem-Cell-Derived Intestinal Organoids.
Qu N; Jeffcoat B; Maity P; Christensen RK; Múnera JO
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955755
[TBL] [Abstract][Full Text] [Related]
25. Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered Chips.
Workman MJ; Gleeson JP; Troisi EJ; Estrada HQ; Kerns SJ; Hinojosa CD; Hamilton GA; Targan SR; Svendsen CN; Barrett RJ
Cell Mol Gastroenterol Hepatol; 2018; 5(4):669-677.e2. PubMed ID: 29930984
[TBL] [Abstract][Full Text] [Related]
26. Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells.
Naumovska E; Aalderink G; Wong Valencia C; Kosim K; Nicolas A; Brown S; Vulto P; Erdmann KS; Kurek D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674311
[TBL] [Abstract][Full Text] [Related]
27. Intestinal organoids in infants and children.
Chusilp S; Li B; Lee D; Lee C; Vejchapipat P; Pierro A
Pediatr Surg Int; 2020 Jan; 36(1):1-10. PubMed ID: 31555860
[TBL] [Abstract][Full Text] [Related]
28. Generation of intestinal organoids derived from human pluripotent stem cells for drug testing.
Yoshida S; Miwa H; Kawachi T; Kume S; Takahashi K
Sci Rep; 2020 Apr; 10(1):5989. PubMed ID: 32249832
[TBL] [Abstract][Full Text] [Related]
29. Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
Jelinsky SA; Derksen M; Bauman E; Verissimo CS; van Dooremalen WTM; Roos JL; Higuera Barón C; Caballero-Franco C; Johnson BG; Rooks MG; Pott J; Oldenburg B; Vries RGJ; Boj SF; Kasaian MT; Pourfarzad F; Rosadini CV
Inflamm Bowel Dis; 2023 Feb; 29(2):195-206. PubMed ID: 36356046
[TBL] [Abstract][Full Text] [Related]
30. A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids.
Takahashi Y; Sato S; Kurashima Y; Yamamoto T; Kurokawa S; Yuki Y; Takemura N; Uematsu S; Lai CY; Otsu M; Matsuno H; Osawa H; Mizushima T; Nishimura J; Hayashi M; Yamaguchi T; Kiyono H
Stem Cell Reports; 2018 Jan; 10(1):314-328. PubMed ID: 29233552
[TBL] [Abstract][Full Text] [Related]
31. 3D culture of mesenchymal stem cells from the yolk sac to generate intestinal organoid.
Motta LCB; Pereira VM; Pinto PAF; Mançanares CAF; Pieri NCG; de Oliveira VC; Fantinato-Neto P; Ambrósio CE
Theriogenology; 2023 Oct; 209():98-106. PubMed ID: 37379588
[TBL] [Abstract][Full Text] [Related]
32. Intestinal organoids as tissue surrogates for toxicological and pharmacological studies.
Kuratnik A; Giardina C
Biochem Pharmacol; 2013 Jun; 85(12):1721-6. PubMed ID: 23623789
[TBL] [Abstract][Full Text] [Related]
33. Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction.
Takayama K; Negoro R; Yamashita T; Kawai K; Ichikawa M; Mori T; Nakatsu N; Harada K; Ito S; Yamada H; Yamaura Y; Hirata K; Ishida S; Mizuguchi H
Cell Mol Gastroenterol Hepatol; 2019; 8(3):513-526. PubMed ID: 31228606
[TBL] [Abstract][Full Text] [Related]
34. Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology.
Zachos NC; Kovbasnjuk O; Foulke-Abel J; In J; Blutt SE; de Jonge HR; Estes MK; Donowitz M
J Biol Chem; 2016 Feb; 291(8):3759-66. PubMed ID: 26677228
[TBL] [Abstract][Full Text] [Related]
35. [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells].
Iwao T
Yakugaku Zasshi; 2018; 138(10):1241-1247. PubMed ID: 30270266
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid promotes barrier functions in human iPSC-derived intestinal epithelial monolayers.
Yamada S; Kanda Y
J Pharmacol Sci; 2019 Aug; 140(4):337-344. PubMed ID: 31399314
[TBL] [Abstract][Full Text] [Related]
37. [Establishment of mini-guts organoid and research on intestinal disease from the new perspective].
Xu ZY; Liu Y; Jiang YG; Huang JJ; Wu XW; Ren JA
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):638-643. PubMed ID: 34289550
[TBL] [Abstract][Full Text] [Related]
38. Suspension culture in a rotating bioreactor for efficient generation of human intestinal organoids.
Takahashi J; Mizutani T; Sugihara HY; Nagata S; Kato S; Hiraguri Y; Takeoka S; Tsuchiya M; Kuno R; Kakinuma S; Watanabe M; Okamoto R
Cell Rep Methods; 2022 Nov; 2(11):100337. PubMed ID: 36452871
[TBL] [Abstract][Full Text] [Related]
39. Protective Effect of Irsogladine against Aspirin-Induced Mucosal Injury in Human Induced Pluripotent Stem Cell-Derived Small Intestine.
Kanno T; Katano T; Ogawa I; Iwao T; Matsunaga T; Kataoka H
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676718
[No Abstract] [Full Text] [Related]
40. Utility of human induced pluripotent stem cell-derived small intestinal epithelial cells for pharmacokinetic, toxicological, and immunological studies.
Imakura Y; Mima S; Yamazaki N; Inomata A; Mochizuki S; Iwao T; Matsunaga T
Biochem Biophys Res Commun; 2024 Jan; 692():149356. PubMed ID: 38071890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
